LIGAND PHARMACEUTICALS INC's ticker is and the CUSIP is 53220KAF5. A total of 44 filers reported holding LIGAND PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $9,719,000 | -2.4% | 10,000,000 | 0.0% | 0.12% | -15.0% |
| Q4 2021 | $9,956,000 | -0.6% | 10,000,000 | 0.0% | 0.15% | +2.8% |
| Q3 2021 | $10,017,000 | -18.9% | 10,000,000 | -20.0% | 0.14% | +49.0% |
| Q2 2021 | $12,354,000 | -4.5% | 12,500,000 | 0.0% | 0.10% | -25.6% |
| Q1 2021 | $12,938,000 | -38.9% | 12,500,000 | -44.4% | 0.13% | -48.0% |
| Q4 2020 | $21,172,000 | +4.3% | 22,500,000 | 0.0% | 0.25% | -14.2% |
| Q3 2020 | $20,292,000 | +2.8% | 22,500,000 | 0.0% | 0.29% | -39.4% |
| Q2 2020 | $19,733,000 | +6.2% | 22,500,000 | 0.0% | 0.48% | -3.8% |
| Q1 2020 | $18,577,000 | -4.3% | 22,500,000 | 0.0% | 0.50% | +13.5% |
| Q4 2019 | $19,418,000 | +3.5% | 22,500,000 | 0.0% | 0.44% | +18.8% |
| Q3 2019 | $18,753,000 | -3.5% | 22,500,000 | 0.0% | 0.37% | +74.4% |
| Q2 2019 | $19,426,000 | – | 22,500,000 | – | 0.21% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CANYON CAPITAL ADVISORS LLC | 40,000,000 | $39,863,000 | 1.36% |
| TFG Asset Management GP Ltd | 21,600,000 | $21,837,000 | 1.32% |
| Penn Mutual Asset Management | 810 | $806,000 | 0.86% |
| WOLVERINE ASSET MANAGEMENT LLC | 47,643,000 | $47,931,000 | 0.45% |
| TENOR CAPITAL MANAGEMENT Co., L.P. | 11,645,000 | $11,750,000 | 0.25% |
| OAKTREE CAPITAL MANAGEMENT LP | 18,672,000 | $18,683,000 | 0.20% |
| PALISADE CAPITAL MANAGEMENT, LP | 9,833,000 | $9,883,000 | 0.20% |
| DAVIDSON KEMPNER CAPITAL MANAGEMENT LP | 10,000,000 | $9,956,000 | 0.15% |
| SSI INVESTMENT MANAGEMENT LLC | 2,500,000 | $2,490,000 | 0.15% |
| AVIVA PLC | 31,500,000 | $31,724,000 | 0.13% |